Diagnostic précoce de la SEP: Jusqu'où ? Comment ?

Revue Neurologique

Volumn 168, Issue 11, 2012, Pages 846-851

  Brassat, D ^a  

^a UNIVERSITÉ PAUL SABATIER   (France)

Author keywords

Chitinase; Clinically isolated syndrome; Genomics; High field MRI; McDonald criteria; Multiple sclerosis; Radiologically isolated syndrome; TOB1; Unsuspected multiple sclerosis

Indexed keywords

BETA INTERFERON; GADOLINIUM; NATALIZUMAB; RNA;

ADULT; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CHILD; DISEASE COURSE; EARLY DIAGNOSIS; FEMALE; GENE; GENETIC SUSCEPTIBILITY; HIGH RISK PATIENT; HUMAN; MALE; MENINGEAL HEMORRHAGE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NEURITIS; REVIEW; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; TOB1 GENE; ASTROCYTOMA; CEREBELLUM TUMOR; FOOTBALL; HEADACHE AND FACIAL PAIN; INJURY; MIDDLE AGED; ONSET AGE; PSYCHOLOGICAL ASPECT; RADIOGRAPHY;

AGE OF ONSET; ASTROCYTOMA; CEREBELLAR NEOPLASMS; CHILD; DISEASE PROGRESSION; FEMALE; FOOTBALL; HEADACHE DISORDERS; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS;

EID: 84869093395     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurol.2012.07.009     Document Type: Review

References (26)

1. M. Clerico, F. Faggiano, J. Palace, G. Rice, M. Tintorè, and L. Durelli Recombinant interferon-beta or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosis Cochrane Database Syst Rev 2008 CD005278 (Review)
2. M. Comabella, M. Fernández, R. Martin, S. Rivera-Vallvé, E. Borrás, and C. Chiva Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis Brain 133 2010 1082 1093
3. A. Compston, and A. Coles Multiple sclerosis Lancet 372 2008 1502 1517
4. J.C. Corvol, D. Pelletier, R.G. Henry, S.J. Caillier, J. Wang, and D. Pappas Abrogation of T cell quiescence characterizes patients at high-risk for multiple sclerosis after the initial neurological event Proc Natl Acad Sci U S A 105 2008 11839 11844
5. N. De Stefano, E. Cocco, M. Lai, M. Battaglini, A. Spissu, and P. Marchi Imaging brain damage in first-degree relatives of sporadic and familial multiple sclerosis Ann Neurol 59 2006 634 639
6. J.J. Gilbert, and M. Sadler Unsuspected multiple sclerosis Arch Neurol 40 1983 533 536
7. P.A. Gourraud, J.P. McElroy, S.J. Caillier, B.A. Johnson, A. Santaniello, and S.L. Hauser Aggregation of multiple sclerosis genetic risk variants in multiple and single case families Ann Neurol 69 2011 65 74
8. O. Gout, C. Lebrun-Frenay, P. Labauge, G.E. Le Page, P. Clavelou, and S. Allouche Prior suggestive symptoms in one-third of patients consulting for a "first" demyelinating event J Neurol Neurosurg Psychiatry 82 2011 323 325
9. A.K. Hedström, E. Sundqvist, M. Bäärnhielm, N. Nordin, J. Hillert, and I. Kockum Smoking and two human leukocyte antigen genes interact to increase the risk for multiple sclerosis Brain 134 2011 653 664
10. International multiple sclerosis genetic consortium Welcome trust case control consortium. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis Nature 476 2011 214 219
11. L.D. Jacobs, R.W. Beck, J.H. Simon, R.P. Kinkel, C.M. Brownscheidle, and T.J. Murray Intramuscular interferon-beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS study group N Engl J Med 343 2000 898 904
12. C. Jersild, A. Svejgaard, and T. Fog HL-A antigens and multiple sclerosis Lancet 1 1972 1240 1241
13. I.D. Kilsdonk, F. Barkhof, and M.P. Wattjes 2010 revisions to McDonald criteria for diagnosis of multiple sclerosis: impact of 3-Tesla magnetic resonance imaging Ann Neurol 70 2011 182 183
14. T. Korteweg, M. Tintoré, B. Uitdehaag, A. Rovira, J. Frederiksen, and D. Miller MRI criteria for dissemination in space in patients with clinically isolated syndromes: a multicentre follow-up study Lancet Neurol 5 2006 221 227
15. C. Lebrun, C. Bensa, M. Debouverie, J. De Seze, S. Wiertlievski, and B. Brochet Unexpected multiple sclerosis: follow-up of 30 patients with magnetic resonance imaging and clinical conversion profile J Neurol Neurosurg Psychiatry 79 2008 195 198
16. C. Lebrun, C. Bensa, M. Debouverie, S. Wiertlevski, D. Brassat, J. de Seze Club francophone de la sclérose en plaques Association between clinical conversion to multiple sclerosis in radiologically isolated syndrome and magnetic resonance imaging, cerebrospinal fluid, and visual evoked potential: follow-up of 70 patients Arch Neurol 66 2009 841 846
17. C. Lebrun, F. Blanc, D. Brassat, H. Zephir, and J. de Seze Cognitive function in radiologically isolated syndrome Mult Scler 16 2010 919 925
18. R.P. Mackay, and A. Hirano Forms of benign multiple sclerosis. Report of two "clinically silent" cases discovered at autopsy Arch Neurol 17 1967 588 600
19. W.I. McDonald, A. Compston, G. Edan, D. Goodkin, H.P. Hartung, and F.D. Lublin Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis Ann Neurol 50 2001 121 127
20. J.R. Oksenberg, and S.E. Baranzini Multiple sclerosis genetics-is the glass half full, or half empty? Nat Rev Neurol 6 2010 429 437
21. D.T. Okuda, E.M. Mowry, A. Beheshtian, E. Waubant, S.E. Baranzini, and D.S. Goodin Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome Neurology 72 2009 800 805
22. C.H. Polman, S.C. Reingold, B. Banwell, M. Clanet, J.A. Cohen, and M. Filippi Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria Ann Neurol 69 2011 292 302
23. C.M. Poser, D.W. Paty, L. Scheinberg, W.I. McDonald, F.A. Davis, and G.C. Ebers New diagnostic criteria for multiple sclerosis: guidelines for research protocols Ann Neurol 13 1983 227 231
24. E.C. Tallantyre, J.E. Dixon, I. Donaldson, T. Owens, P.S. Morgan, and P.G. Morris Ultra-high-field imaging distinguishes MS lesions from asymptomatic white matter lesions Neurology 76 2011 534 539
25. S. Sawcer, M. Ban, J. Wason, and F. Dudbridge What role for genetics in the prediction of multiple sclerosis? Ann Neurol 67 2010 3 10
26. K. Schmierer, H.G. Parkes, P.W. So, S.F. An, S. Brandner, and R.J. Ordidge High-field (9.4 Tesla) magnetic resonance imaging of cortical grey matter lesions in multiple sclerosis Brain 133 2010 858 867